Clinical Trials Insight: 700046359
Phase of Trial: Phase I
Latest Information Update: 25 Aug 2010
At a glance
- Drugs ADX 71149 (Primary)
- Indications Anxiety disorders; CNS disorders; Depressive disorders; Schizophrenia
- Focus Adverse reactions
- Sponsors Janssen Research & Development
- 25 Aug 2010 Status changed from recruiting to completed according to information in an Addex Pharmaceuticals media release.
- 29 Jun 2009 New trial record.